U.S. Physical Therapy - USPH Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" USPH shares.
View USPH analyst ratings or view top-rated stocks.

1 brokers have issued 12 month target prices for U.S. Physical Therapy's stock. Their USPH share price forecasts range from $120.00 to $123.00. On average, they anticipate the company's share price to reach $121.50 in the next twelve months. This suggests a possible upside of 43.2% from the stock's current price.
View analysts price targets for USPH or view top-rated stocks among Wall Street analysts.

U.S. Physical Therapy's stock was trading at $95.55 at the start of the year. Since then, USPH shares have decreased by 11.2% and is now trading at $84.87.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our USPH earnings forecast.

U.S. Physical Therapy, Inc. (NYSE:USPH) announced its quarterly earnings data on Thursday, November, 4th. The company reported $0.85 EPS for the quarter, topping analysts' consensus estimates of $0.78 by $0.07. The company earned $125.90 million during the quarter, compared to analyst estimates of $124.67 million. U.S. Physical Therapy had a net margin of 7.34% and a trailing twelve-month return on equity of 12.30%. The firm's revenue was up 15.6% on a year-over-year basis. During the same period last year, the firm earned $0.86 EPS.

U.S. Physical Therapy declared a quarterly dividend on Wednesday, November 2nd. Investors of record on Monday, November 21st will be paid a dividend of $0.41 per share on Friday, December 16th. This represents a $1.64 dividend on an annualized basis and a dividend yield of 1.93%. The ex-dividend date of this dividend is Friday, November 18th.
Read our dividend analysis for USPH.

U.S. Physical Therapy (NYSE:USPH) pays an annual dividend of $1.64 per share and currently has a dividend yield of 1.98%. The company has been increasing its dividend for 3 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 54.85%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, USPH will have a dividend payout ratio of 56.75% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for USPH.

U.S. Physical Therapy issued an update on its FY 2022 earnings guidance on Wednesday, November, 9th. The company provided earnings per share guidance of $2.65-$2.75 for the period, compared to the consensus earnings per share estimate of $2.71. The company issued revenue guidance of -.

38 employees have rated U.S. Physical Therapy Chief Executive Officer Chris Reading on Glassdoor.com. Chris Reading has an approval rating of 49% among the company's employees. This puts Chris Reading in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), NVIDIA (NVDA), AbbVie (ABBV), CVS Health (CVS), Gilead Sciences (GILD), International Business Machines (IBM), Illumina (ILMN), Johnson & Johnson (JNJ), Lowe's Companies (LOW) and Marathon Petroleum (MPC).

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

U.S. Physical Therapy's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (15.57%), Kayne Anderson Rudnick Investment Management LLC (11.86%), Vanguard Group Inc. (7.22%), Eaton Vance Management (4.36%), Boston Trust Walden Corp (3.92%) and Copeland Capital Management LLC (3.72%). Insiders that own company stock include Anne Motsenbocker, Bernard A Harris Jr, Bernard A Harris, Jr, Christopher J Reading, Christopher J Reading, Edward L Kuntz, Eric Joseph Williams, Glenn Mcdowell, Graham D Reeve, Graham D Reeve, Harry S Chapman, Harry S Chapman, Kathleen A Gilmartin, Lawrance W Mcafee, Mark J Brookner, Regg E Swanson and Richard Binstein.
View institutional ownership trends.

Shares of USPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of USPH stock can currently be purchased for approximately $84.87.

U.S. Physical Therapy (NYSE:USPH) has a market capitalization of $1.10 billion and generates $495.02 million in revenue each year. The company earns $40.83 million in net income (profit) each year or $2.99 on an earnings per share basis.

The company employs 5,500 workers across the globe.

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The official website for the company is www.usph.com. The company can be reached via phone at (713) 297-7000, via email at lmcafee@usph.com, or via fax at 713-297-7090.